<DOC>
	<DOCNO>NCT00712686</DOCNO>
	<brief_summary>The purpose study compare efficacy tolerability aripiprazole olanzapine 26 week treatment schizophrenia</brief_summary>
	<brief_title>Comparative Study Aripiprazole Olanzapine Treatment Patients With Acute Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients DSMIV diagnosis schizophrenia patient acute relapse Treated outpatient least one continuous 3month period past 12 month PANSS total score â‰¥60 Previously responsive neuroleptic ( clozapine ) Able give inform consent comprehend satisfactorily comply protocol requirement An Axis I ( DSMIV ) diagnosis schizoaffective disorder A clinical picture and/or history consistent : ( ) Delirium , dementia , amnestic cognitive disorder ; ( b ) Bipolar disorder ; ( c ) personality disorder Nonresponsive prior olanzapine therapy Likely require prohibit concomitant therapy DSMIV criterion significant substance abuse within past three month , include addiction cocaine alcohol Known allergic hypersensitive study drug Represented significant risk commit suicide base history mental status exam Unstable thyroid pathology treatment within past six month A history evidence medical condition would expose patient undue risk Clinically significant abnormal laboratory test result ( include urine drug screen ) , vital sign , ECG finding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>